Image pharmaphorum Editor Debates & Insight Sponsored From promise to practice: immuno-oncology in action – the ne... Immuno-oncology therapies that harness the body's own defences to fight off tumours are widely acknowledged as the new frontier in cancer treatment. Debates & Insight Sponsored Available on demand: Patient centricity 101 – How to create ... Debates & Insight Sponsored Available on demand: Why the success of your HTA will rely o... Debates & Insight Sponsored Available on demand – Predicting success: How advanced analy... Load more results
Debates & Insight Sponsored From promise to practice: immuno-oncology in action – the ne... Immuno-oncology therapies that harness the body's own defences to fight off tumours are widely acknowledged as the new frontier in cancer treatment.
News US lawmakers take FDA to task over rare diseases record Lawmakers and patient advocates in the US are concerned that the FDA's regulation of rare disease therapies has been inconsistent and overly cautious.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
